N4 Pharma PLC
LSE:N4P

Watchlist Manager
N4 Pharma PLC Logo
N4 Pharma PLC
LSE:N4P
Watchlist
Price: 0.525 GBX Market Closed
Market Cap: 4.4m GBX

Operating Margin
N4 Pharma PLC

-16 919.7%
Current
-18 057%
Average
6%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-16 919.7%
=
Operating Profit
-1.2m
/
Revenue
7.1k

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
UK
N4 Pharma PLC
LSE:N4P
4.4m GBP
-16 920%
US
Eli Lilly and Co
NYSE:LLY
1T USD
44%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
3%
US
Johnson & Johnson
NYSE:JNJ
496.6B USD
27%
CH
Roche Holding AG
SIX:ROG
259.2B CHF
34%
UK
AstraZeneca PLC
LSE:AZN
212B GBP
24%
CH
Novartis AG
SIX:NOVN
208.2B CHF
33%
US
Merck & Co Inc
NYSE:MRK
251.4B USD
38%
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK
42%
IE
Endo International PLC
LSE:0Y5F
209B USD
11%
US
Pfizer Inc
NYSE:PFE
143.2B USD
29%
No Stocks Found

N4 Pharma PLC
Glance View

Market Cap
4.4m GBX
Industry
Pharmaceuticals

N4 Pharma Plc is a pharmaceutical company, which engages in the reformulation of existing drugs and vaccines. The company is headquartered in Derby, Derbyshire and currently employs 5 full-time employees. The company went IPO on 2005-06-07. The firm is engaged in engaged in the development of mesoparticulate silica delivery systems to improve the cellular delivery and potency of vaccines. The company is focused on developing a delivery system for vaccines and cancer treatments using its silica nanoparticle delivery system called Nuvec. Nuvec is a non-viral adjuvant delivery system that has the potential to revolutionize vaccines and cancer treatments. The company is focused on development and commercialization of medicines via its delivery system.

N4P Intrinsic Value
0.006 GBX
Overvaluation 99%
Intrinsic Value
Price
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-16 919.7%
=
Operating Profit
-1.2m
/
Revenue
7.1k
What is the Operating Margin of N4 Pharma PLC?

Based on N4 Pharma PLC's most recent financial statements, the company has Operating Margin of -16 919.7%.

Back to Top